Ref. Daily Telegraph article, The NHS, the drug firms ... June 21st, 2013
In response
to an article in The Daily Telegraph on Friday 21st June, The
Association of Pharmaceutical Specials Manufacturers, APSM, has stated that it
strongly condemns any activity that would result in overcharging for supply of
medicines to the NHS. The Daily Telegraph article alleges activity to
overcharge on medicines, based on interviews with individuals working in the
specials industry.
The
allegations in the Daily Telegraph article, if proven, would not be considered
acceptable practice at any level and would not be reflective of the vast
majority of specials manufacturers in the UK.
The APSM,
which represents manufacturers of unlicensed medicines (specials) within the
UK, has worked closely with the Department of Health in recent years to develop
a more transparent system of pricing and supply that protects the interests of
patients and the NHS. The specials sector provides a vitally important
service and those involved take a responsible and long term approach to
promoting best practice in line within the pharmaceutical
sector.
The
Association of Pharmaceutical Specials Manufacturers, APSM, sets out a Code of
Conduct to which all APSM Members subscribe. The APSM can consider an alleged
breach of the code by a member.
One of the
companies mentioned by the Daily Telegraph, Quantum Pharmaceuticals, is a
member of the APSM. APSM understands that Quantum has carried out an internal
investigation following the allegations and has denied the allegations made by
the Daily Telegraph relating to overcharging.
For more
information:
07734
101024
Comments
Post a Comment